FDA catalysts, PDUFA dates with approval probability, drug pipeline, cash runway and insider activity — updated automatically from SEC, FDA and ClinicalTrials.gov data.
| Date | Drug | Type | Run-up 30d | Decision 1d | After 5d |
|---|---|---|---|---|---|
| 2025-05-06 | Narsoplimab | BLA | -7.5% | -6.9% | -44.2% |
A free BioRadar account adds AI daily briefings, sentiment tracking, trial enrollment progress, and email alerts for OMER and 2 more tickers of your choice.
Create Free Account →